BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 1998

View Archived Issues

Combination therapy incorporating antioxidants effective for treatment of H. pylori infection

Read More

Metrifonate appears to be beneficial for the treatment of mild to moderate AD

Read More

Transkaryotic Therapies: Q1 1998 highlights

Read More

E-4010: a potential new treatment for pulmonary hypertension

Read More

Scotia updates R&D portfolio

Read More

Anxiolytic and antidepressant effects of L-701324, a glycine receptor antagonist

Read More

Roche now copromoting Coreg with SKB

Read More

More European approvals obtained for balsalazide

Read More

Benzodiazepine agonists and their use described by Synthelabo

Read More

Pfizer discloses new CRF (CRH) antagonists

Read More

Novel glutamate receptor antagonists in development at Warner-Lambert

Read More

Exemestane now under regulatory review, P&U reports

Read More

CNRS investigators discover CFTR channel activators

Read More

Hydroxamic and carboxylic acid derivatives as inhibitors of MMPs and TNF production

Read More

Ro-19-4603 attenuates ethanol responding in alcohol-preferring rats

Read More

AltaRex outlines corporate strategy for next 12 to 18 months

Read More

Osiris awarded patent for the use of MSCs in bone marrow regeneration

Read More

New GABA-B antagonist shows memory-enhancing effects in rats

Read More

5-HT antibodies for treatment of alcoholism

Read More

Terrapin changes name to Telik to reflect company's progress

Read More

Peptide Therapeutics and Pasteur Merieux-OraVax to develop H. pylori vaccine

Read More

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

Read More

Myriad Genetics enters into agreement with Rockefeller University for cancer gene research

Read More

Isis and Ciba Vision file MAA for fomivirsen

Read More

Manganic porphyrins for treatment of hyperoxic lung injury

Read More

Corixa obtains option to license mammaglobin for the diagnosis of breast cancer

Read More

Profile of BIIC-1996, a novel dual NK1/NK2 antagonist for respiratory indications

Read More

Serono introduces Geref for treatment/diagnosis of GHD

Read More

P&U reports antiasthma agent with a novel mechanism of action

Read More

Levalbuterol shows improved therapeutic ratio over racemic albuterol

Read More

Proteus seeks partners, licensees for novel hypertension vaccine

Read More

Phase III trials with SB-207499 begin

Read More

Rebif reduces disease activity in patients with MS

Read More

Immunex completes BLA submission for Enbrel

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 27, 2026.
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing